- Home
- TCRX vs TSQ Comparison
TCRX vs TSQ Comparison
Compare TCRX & TSQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCRX
- TSQ
- Stock Information
- Founded
- TCRX 2018
- TSQ 1996
- Country
- TCRX United States
- TSQ United States
- Employees
- TCRX N/A
- TSQ N/A
- Industry
- TCRX Biotechnology: Pharmaceutical Preparations
- TSQ Broadcasting
- Sector
- TCRX Health Care
- TSQ Consumer Discretionary
- Exchange
- TCRX Nasdaq
- TSQ Nasdaq
- Market Cap
- TCRX 115.8M
- TSQ 131.9M
- IPO Year
- TCRX 2021
- TSQ 2000
- Fundamental
- Price
- TCRX $2.17
- TSQ $8.72
- Analyst Decision
- TCRX Strong Buy
- TSQ Strong Buy
- Analyst Count
- TCRX 5
- TSQ 3
- Target Price
- TCRX $11.40
- TSQ $16.83
- AVG Volume (30 Days)
- TCRX 382.5K
- TSQ 48.2K
- Earning Date
- TCRX 03-05-2025
- TSQ 03-17-2025
- Dividend Yield
- TCRX N/A
- TSQ 9.06%
- EPS Growth
- TCRX N/A
- TSQ N/A
- EPS
- TCRX N/A
- TSQ N/A
- Revenue
- TCRX $9,362,000.00
- TSQ $447,955,000.00
- Revenue This Year
- TCRX N/A
- TSQ N/A
- Revenue Next Year
- TCRX $5.14
- TSQ $0.24
- P/E Ratio
- TCRX N/A
- TSQ N/A
- Revenue Growth
- TCRX N/A
- TSQ N/A
- 52 Week Low
- TCRX $1.99
- TSQ $8.70
- 52 Week High
- TCRX $9.69
- TSQ $13.57
- Technical
- Relative Strength Index (RSI)
- TCRX 37.12
- TSQ 38.30
- Support Level
- TCRX $2.02
- TSQ $8.76
- Resistance Level
- TCRX $2.17
- TSQ $9.12
- Average True Range (ATR)
- TCRX 0.16
- TSQ 0.26
- MACD
- TCRX 0.02
- TSQ 0.00
- Stochastic Oscillator
- TCRX 26.47
- TSQ 2.94
About TCRX TScan Therapeutics Inc.
TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.
About TSQ Townsquare Media Inc.
Townsquare Media Inc is a radio, digital media, entertainment, and digital marketing solutions company principally focused on being the premier local advertising and marketing solutions platform in small and mid-sized markets across the United States. It has three segments which are Subscription Digital Marketing Solutions, Digital Advertising, and Broadcast Advertising. It earns the majority of the revenue from the Broadcasting Advertising segment, which includes its local, regional, and national advertising products and solutions delivered via terrestrial radio broadcast. Its portfolio includes local media brands such as WYRK.com, WJON.com, and NJ101.5.com, and premier national music brands such as XXLmag.com, TasteofCountry.com, UltimateClassicRock.com, and Loudwire.com.